Role Of Bala Taila Nasya And Rasnadi Guggulu in Chronic Suppurative Otitis Media

Not Applicable

• Conditions: Health Condition 1: H661- Chronic tubotympanic suppurative otitis media

• Registration Number: CTRI/2020/04/024829
• Lead Sponsor: Gurukul Campus

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

2.Patient having the symptoms of Vedna (earache), Karnasrava (ear discharge), perforation of TM, hearing impairment, and tenderness over mastoid antrum .

3.Clinically confirming the symptoms of (Karnasrava) Chronic suppurative otitis media by Otoscopic examination.

4.Tubotympanic type of chronic suppurative otitis media.

Exclusion Criteria

1.Patient with complications of chronic suppurative otitis media.

2.Patient suffering from Diabetes Mellitus, HTN and Tuberculosis.

3.Pregnant and lactating females.

4.Patient below the age of 10 and above 60 years.

5.Patient not willing to participate in the study.

6.Atticoantral type of chronic suppurative otitis media.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To access the effect of therapy and medicine, objectively all signs and symptoms were given scoring depending upon their severity: <br/ ><br>1.Cured: 80-100% relief in signs and symptoms <br/ ><br>2.Markedly improved: 60-79% relief in signs and symptoms <br/ ><br>3.Moderately improved: 40-59% relief in signs and symptoms <br/ ><br>4.Mild improvement: 20-39% relief in signs and symptoms <br/ ><br>5.No improvement: less than or equal to 19% relief in symptomsTimepoint: Assessment will be done on 1st, 7th and 17th day of trial and Follow up will be carried out after completion of trial on every 15 day for 1 month.

Secondary Outcome Measures

Name	Time	Method
Exacerbation of signs and symptomsTimepoint: 47 Days (17 days for trial and Follow up for 01 month)